Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance and Healthcare Utilization in Patients with Inflammatory Bowel Disease

被引：0
|
作者：
Sumedha V. Chablani
Claudia Ramos-Rivers
David G. Binion
Eva Szigethy
机构：
[1] UPMC Montefiore Hospital,Department of Medicine
[2] UPMC Presbyterian Hospital M2,Division of Gastroenterology, Hepatology and Nutrition
[3] Visceral Inflammation and Pain (VIP) Center,Division of Gastroenterology, Hepatology and Nutrition
来源：
Digestive Diseases and Sciences | 2018年 / 63卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2482 / 2484
页数：2
相关论文
共 50 条
  • [21] Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?
    Park, Jihye
    Cheon, Jae Hee
    GUT AND LIVER, 2021, 15 (05) : 641 - 642
  • [22] Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients
    Lew, Daniel
    Yoon, Soon Man
    Yan, Xiaofei
    Robbins, Lori
    Haritunians, Talin
    Liu, Zhenqiu
    Li, Dalin
    McGovern, Dermot P. B.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (40) : 7265 - 7273
  • [23] Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients
    Daniel Lew
    Soon Man Yoon
    Xiaofei Yan
    Lori Robbins
    Talin Haritunians
    Zhenqiu Liu
    Dalin Li
    Dermot PB McGovern
    World Journal of Gastroenterology, 2017, (40) : 7265 - 7273
  • [24] Clinical Features and Outcomes of Tuberculosis in Inflammatory Bowel Disease Patients Treated with Anti-tumor Necrosis Factor Therapy
    Kim, Jihye
    Im, Jong Pil
    Yim, Jae-Joon
    Lee, Chang Kyun
    Park, Dong Il
    Eun, Chang Soo
    Jung, Sung-Ae
    Shin, Jeong Eun
    Lee, Kang-Moon
    Cheon, Jae Hee
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2020, 75 (01): : 29 - +
  • [25] Association of Anti-Tumor Necrosis Factor Therapy With Mortality Among Veterans With Inflammatory Bowel Disease
    Cohen-Mekelburg, Shirley
    Wallace, Beth I.
    Van, Tony
    Wiitala, Wyndy L.
    Govani, Shail M.
    Burns, Jennifer
    Lipson, Rachel
    Yun, Huifeng
    Hou, Jason
    Lewis, James D.
    Dominitz, Jason A.
    Waljee, Akbar K.
    JAMA NETWORK OPEN, 2021, 4 (03)
  • [26] Therapeutic Drug Monitoring and Safety of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (04) : 854 - 855
  • [27] Decreased Risk of Preeclampsia in Women with Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy
    Nisha B. Patel
    Daniela Guerrero Vinsard
    Andrea G. Kattah
    Sunanda V. Kane
    Digestive Diseases and Sciences, 2023, 68 : 3557 - 3561
  • [28] Decreased Risk of Preeclampsia in Women with Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy
    Patel, Nisha B.
    Vinsard, Daniela Guerrero
    Kattah, Andrea G.
    Kane, Sunanda V.
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (09) : 3557 - 3561
  • [29] Anti-Tumor Necrosis Factor Alpha Antibodies for Remission Maintenance Therapy in Inflammatory Bowel Disease
    Neubauer, Katarzyna
    Kempinski, Radoslaw
    Poniewierka, Elzbieta
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 19 (02): : 143 - 149
  • [30] Severe Skin Lesions Cause Patients With Inflammatory Bowel Disease to Discontinue Anti-Tumor Necrosis Factor Therapy
    Rahier, Jean-Francois
    Buche, Sebastien
    Peyrin-Biroulet, Laurent
    Bouhnik, Yoram
    Duclos, Bernard
    Louis, Edouard
    Papay, Pavol
    Allez, Matthieu
    Cosnes, Jacques
    Cortot, Antoine
    Laharie, David
    Reimund, Jean-Marie
    Lemann, Marc
    Delaporte, Emmanuel
    Colombel, Jean-Frederic
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (12) : 1048 - 1055
12345